Citations

Clear

1032 citation(s) found for "Murray, J A".

Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay
Turner, Katherine A., Eckelkamp, Laura L, Kalass, Stephanie, Martinez, Mark, Brewer, Hayley R, Hoyne, Jonathan , Snyder, Melissa R. , Murray, David , Kalass, Stephanie J, Martinez, Mark A, Hoyne, Jonathan B, Murray, David L., Willrich, Maria A V, Martinez, Mark A, Willrich, Maria Alice V.

Mayo Clinic

Clinical Chemistry | August 6, 2019 | Volume: 65 | Issue: 10 | Pages: 1327-1329

10.1373/clinchem.2019.306456 | PMID 31387883 Get It

Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome
Sakae, Nobutaka, Josephs, Keith A. , Murray, Melissa E. , Duara, Ranjan , Uitti, Ryan J. , Gerpen, Jay Van, Graff-Radford, N. R., Van Gerpen, Jay, Graff-Radford, Neil R, Murray, Melissa E , Litvan, Irene , Duara, Ranjan , Wszołek, Zbigniew K. , Gerpen, Jay A. van, Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | August 6, 2019 | Volume: 15 | Issue: 9 | Pages: 1218-1228

10.1016/j.jalz.2019.04.011 | PMID 31399334 Get It

Abstract Introduction The corticobasal syndrome (CBS) is associated with several neuropathologic disorders, including corticobasal degeneration and Alzheimer's disease (AD). Method In this report, we studied 43 AD patients with CBS (AD‐CBS) and compared them with 42 AD patients with typical amnestic syndrome (AD‐AS), as well as 15 cases of corticobasal degeneration and CBS pathology. Results Unlike AD‐AS, AD‐CBS had prominent motor problems, including limb apraxia (90%), myoclonus (81%), and gait disorders (70%). Alien limb phenomenon was reported in 26% and cortical sensory loss in 14%. Language problems were also more frequent in AD‐CBS, and memory impairment was less frequent. AD‐CBS had more tau pathology in perirolandic cortices but less in superior temporal cortex than AD‐AS. In addition, AD‐CBS had greater neuronal loss in the substantia nigra. Discussion AD‐CBS is a clinicopathological subtype of AD with an atypical distribution of Alzheimer‐type tau pathology. Greater neuronal loss in the substantia nigra may contribute to Parkinsonism which is not a feature of typical AD.
Postoperative Recovery Comparisons of Arthroscopic Bankart to Open Latarjet for the Treatment of Anterior Glenohumeral Instability
Smith, Jennifer , Higgins, Laurence D. , Woodmass, Jarret Murray , Wagner, Eric R. , Warner, Jon J.P.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | July 29, 2019 | Volume: 7 | Issue: 7_suppl5 | Pages: No page available

10.1177/2325967119s00272 Get It

Objectives: Recurrent anterior glenohumeral instability is a disabling pathology that can be successfully treated by arthroscopic Bankart repair or an open Latarjet procedure. Long-term outcomes have shown lower rates of apprehension, recurrent dislocation and operative revision following Latarjet when compared to Bankart repair. However, there is a paucity of studies comparing the short-term post-operative recovery of arthroscopic Bankart versus open Latarjet. The purpose of this study is to evaluate the post-operative recovery following Bankart and the open Latarjet procedure. Methods: The surgical outcomes system (SOS) database (Arthrex Inc., Naples, FL) was used to compare the post-operative recovery outcomes after either a primary or revision arthroscopic Bankart and an open Latarjet procedure. Patients were included who had a minimum of 1 year follow-up. Preoperative and postoperative (2 weeks, 6 weeks, 3 months, 6 months, 1 year and 2 year) time points were evaluated. Outcomes measures included Visual Analog Pain Scale (VAS), American Shoulder and Elbow Surgeons (ASES) Shoulder Function Score, ASES Shoulder Index Score, and SANE Score. Overall, 787 patients underwent primary Bankart (518 male, 240 female, 4 not recorded), 36 underwent revision Bankart (24 male, 10 female, 2 not recorded) and 75 underwent an open Latarjet procedure (59 male, 12 female, 4 not recorded). The mean age for primary Bankart, revision Bankart, and open Latarjet was 40.8, 38.6 and 32.8 respectively. Additionally, the average BMI for primary Bankart, revision Bankart, and open Latarjet was 27.2, 28.13, and 25.6, respectively. Results: The postoperative recovery curves are displayed in Figure 1. When compared to primary Bankart, open Latarjet demonstrated significantly lower VAS scores at six weeks (p=0.0272) and at three months (p=0.0094). Medium term outcomes for ASES Shoulder Index Score, ASES Shoulder Function Score, and SANE Score, at 1- and 2-years showed no difference between primary Bankart and Latarjet. For the revision Bankart and open Latarjet procedures, the open Latarjet cohort demonstrated significantly higher ASES Shoulder Index Scores at the 3-months (p= 0.0017), 1-year (p= 0.0021), and 2-years (p= 0.0006) timepoints. Open Latarjet patients also had significantly higher ASES Shoulder Function Scores than revision Bankart at 3-months (p= 0.0162), 1-year (p= 0.0083), and 2-years (p= 0.0013). Revision Bankart repair resulted in significantly higher VAS scores than open Latarjet at 2-weeks (p= 0.0025), 6-weeks (p=0.0114), 3-months (p= 0.0024), 1-year (p= 0.0039), and 2-years (p= 0.0007). Conclusion: When compared to Bankart repair, open Latarjet provides improved pain and functional outcomes during the early recovery phase, 2-weeks, 6-weeks, 3-months, and 6-months, with equivalent medium-term outcomes at 1-2-years. Furthermore, when compared to revision Bankart reconstruction, open Latarjet provides improved ASES Shoulder Index Scores, ASES Shoulder Function Scores and VAS Scores at nearly all timepoints. In the treatment of recurrent anterior glenohumeral instability, open Latarjet is reasonable option in the primary setting and should be favored over Bankart repair for revision cases with improved pain relief and functional scores.
Comparison of eVisit Management of Urinary Symptoms and Urinary Tract Infections with Standard Care
Murray, Martha A. , Penza, Kristine S , Myers, Jane F., Furst, Joseph W. , Pecina, Jennifer L. , Pecina, Jennifer

Mayo Clinic

Telemedicine and e-Health | July 17, 2019 | Volume: 26 | Issue: 5 | Pages: 639-644

10.1089/tmj.2019.0044 | PMID 31313978 Get It

Commentary
Murray, David , Murray, David L.

Mayo Clinic

Clinical Chemistry | June 28, 2019 | Volume: 65 | Issue: 7 | Pages: 837-838

10.1373/clinchem.2019.302901 | PMID 31253609 Get It

Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease
Kasanuki, Koji , Brennan, Rebecca, Vargas, Emily , Soto, Alexandra I., Murray, Melissa E. , Koga, Shunsuke , Ross, Owen A. , Valentino, Rebecca R. , Brennan, Rebecca R, Labbé, Catherine, Vargas, Emily R, Koga, Shunsuke , Ross, Owen A , Murray, Melissa E , Heckman, Michael G. , Labbé, Catherine , Dickson, Dennis W.

Mayo Clinic

Movement Disorders | June 25, 2019 | Volume: 34 | Issue: 9 | Pages: 1325-1332

10.1002/mds.27773 | PMID 31234228 Get It

AbstractBackgroundGenetic variation at the microtubule‐associated protein tau locus is associated with clinical parkinsonism. However, it is unclear as to whether microtubule‐associated protein tau H1 subhaplotypes are associated with the burden of neuropathological features of Lewy body disease.ObjectivesTo evaluate associations of microtubule‐associated protein tau haplotypes with severity of Lewy body pathology and markers of SN neuronal loss in Lewy body disease cases.MethodsFive hundred eighty‐five autopsy‐confirmed Lewy body disease cases were included. Six microtubule‐associated protein tau variants (rs1467967, rs242557, rs3785883, rs2471738, rs8070723, and rs7521) were genotyped to define common microtubule‐associated protein tau haplotypes. Lewy body counts were measured in five cortical regions. Ventrolateral and medial SN neuronal loss were assessed semiquantitatively. Nigrostriatal dopaminergic degeneration was quantified by image analysis of tyrosine hydroxylase immunoreactivity in the dorsolateral and ventromedial putamen.ResultsThe common microtubule‐associated protein tau H2 haplotype did not show a strong effect on pathological burden in Lewy body disease. The rare H1j haplotype (1.3%) was significantly associated with a lower dorsolateral putaminal tyrosine hydroxylase immunoreactivity (and therefore greater dopaminergic degeneration) compared to other microtubule‐associated protein tau haplotypes (P = 0.0016). Microtubule‐associated protein tau H1j was also nominally (P ≤ 0.05) associated with a lower ventromedial putaminal tyrosine hydroxylase immunoreactivity (P = 0.010), but this did not survive multiple testing correction. Other nominally significant associations between microtubule‐associated protein tau H1 subhaplotypes and neuropathological outcomes were observed.ConclusionsA rare microtubule‐associated protein tau H1 subhaplotype (H1j) may be associated with more severe putaminal dopaminergic degeneration in Lewy body disease cases. Microtubule‐associated protein tau H1j has been associated previously with an increased risk of PD, and therefore our exploratory findings provide insight into the mechanism by which H1j modulates PD risk. © 2019 International Parkinson and Movement Disorder Society
Evaluation of Associations of Alzheimer’s Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures
Sakae, Nobutaka, Vargas, Emily , Carrasquillo, Minerva M. , Murray, Melissa E. , Kasanuki, Koji , Ertekin‐Taner, Nilüfer , Younkin, Steven G. , Vargas, Emily R, Murray, Melissa E , Heckman, Michael G. , Carrasquillo, Minerva M. , Dickson, Dennis W.

Mayo Clinic

Journal of Alzheimer's Disease | June 25, 2019 | Volume: 70 | Issue: 3 | Pages: 659-666

10.3233/jad-190451 | PMID 31256143 Get It

The Risk of Autoimmune Disorders in Treated Celiac Disease Patients in Olmsted County, Minnesota
Khan, Muhammad Rehan , Nellikkal, Shilpa , Barazi, Ahmed, Larson, Joseph J. , Absah, Imad , Murray, Joseph A.

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | June 18, 2019 | Volume: 69 | Issue: 4 | Pages: 438-442

10.1097/mpg.0000000000002418 | PMID 31219935 Get It

ABSTRACTBackground:Patients with autoimmune disorders (ADs) are at increased risk for celiac disease (CD), but data are conflicting on the risk of ADs in treated patients with CD. We aimed to assess the incidence of ADs in treated patients with CD.Methods:Using the Rochester Epidemiology Project, we retrospectively searched for the medical records at Mayo Clinic and Olmsted Medical Center from January 1997 to December 2015 for patients with CD who met accepted diagnostic criteria. For each patient with CD, we identified 2 age and sex‐matched controls during the same study period. The incidence rate of AD diagnosis 5 years after index date was calculated using Kaplan‐Meier analysis for the CD cases and controls and compared using the log‐rank test.Results:We identified 249 treated patients with CD during the study period and 498 matched controls, with mean (standard deviation) ages of 32 (22) years and 33 (22) years, respectively. One third of patients (n = 85) and controls (n = 170) were boys. Five years after the index date, 5.0% of patients with CD and 1.3% of controls had a de novo AD diagnosis (P = 0.006). In the presence of a prior AD, the cumulative risk of a de novo or additional AD was significantly higher in the CD group compared with controls (P < 0.001). Children had a significantly higher risk of AD development compared with adults (P = 0.010).Conclusions:Treated patients with CD are at higher risk for the development of ADs. The risk of a new AD is higher in children, especially when >1 AD diagnosis exists.